Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Healthy
Interventions
DRUG

Lisinopril 10 mg tablets of PT Dexa Medica

Each tablet contains 10.89 mg of lisinopril dihydrate that equal to 10 mg lisinopril. Test product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

DRUG

Lisinopril 10 mg tablets of PT Boehringer Ingelheim Indonesia

Each tablet contains 10.89 mg of lisinopril dihydrate that equal to 10 mg lisinopril. Reference product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT01936012 - Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition | Biotech Hunter | Biotech Hunter